Cipla Ltd
₹1328
+13.40 (1.02%)
Sun, 25 Oct 2026, 08:00 am
Health Technology
Pharmaceuticals: Other
24.5KCipla Ratios
| Particulars | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Price to earnings ratio | 32.67 | 27.38 | 24.36 | 22.15 | 24.61 | 26.06 | 21.37 | 19.74 | 22.22 | 48.51 | 30.33 | 47.38 | 31.04 | 27.95 | 22.07 | 27.37 | 32.68 | 25.96 | 29.30 | 22.10 |
| Price to book ratio | 10.01 | 5.66 | 4.55 | 3.93 | 4.58 | 3.87 | 3.20 | 3.38 | 3.07 | 5.29 | 3.57 | 3.80 | 3.07 | 2.84 | 2.16 | 3.59 | 3.94 | 3.11 | 4.52 | 3.73 |
| Price to sales ratio | 6.87 | 5.32 | 4.26 | 3.44 | 4.97 | 4.20 | 3.56 | 3.76 | 3.15 | 5.23 | 3.07 | 3.35 | 2.92 | 2.64 | 2.03 | 3.45 | 3.79 | 3.20 | 4.70 | 4.24 |
| Price to cash flow ratio | 73.61 | 51.18 | 45.70 | 47.15 | 25.45 | 25.05 | 14.11 | 20.90 | 20.47 | 55.20 | 25.97 | 21.35 | 31.77 | 26.61 | 11.55 | 17.80 | 24.94 | 22.13 | 28.23 | 22.28 |
| Enterprise value | 20274Cr | 18281Cr | 17582Cr | 17889Cr | 26579Cr | 26265Cr | 23410Cr | 29194Cr | 31660Cr | 58223Cr | 45352Cr | 50760Cr | 46137Cr | 44605Cr | 35502Cr | 64327Cr | 78922Cr | 67571Cr | 114000Cr | 106000Cr |
| Enterprise value to EBITDA ratio | 33.72 | 26.41 | 27.67 | 18.56 | 23.52 | 22.97 | 14.74 | 14.22 | 17.15 | 32.93 | 18.14 | 21.21 | 16.92 | 14.94 | 11.80 | 15.30 | 17.14 | 13.31 | 17.85 | 14.93 |
| Debt to equity ratio | 0.24 | 0.04 | 0.15 | 0.22 | 0 | 0.09 | 0 | 0.11 | 0.12 | 0.16 | 0.45 | 0.33 | 0.29 | 0.29 | 0.20 | 0.11 | 0.05 | 0.03 | 0.02 | 0.01 |
| Return on equity % | 34.36 | 25.60 | 20.05 | 19.03 | 21.11 | 15.74 | 16 | 18.55 | 14.56 | 11.33 | 12.19 | 8.37 | 10.54 | 10.45 | 10.05 | 14.11 | 12.85 | 12.66 | 16.45 | 18.21 |
Cipla Ltd Ratios
The Cipla Ltd Ratios page provides a complete fundamental analysis of Cipla Ltd using key valuation, profitability, and financial strength metrics. Investors tracking Cipla Ltd Ratios closely monitor D/E, EV, EV/EBITDA, P/B, P/CF, P/E, P/S, and ROE% to evaluate the company's financial performance and valuation trends over time.
Cipla Ltd (NSE: CIPLA, BSE: 500087) is currently trading at ₹1328, with a market capitalization of ₹106061.29Cr. As a major player in the Health technology sector and Pharmaceuticals: other industry, Cipla Ltd remains a key stock for fundamental analysis using Cipla Ltd Ratios.
Cipla Ltd Ratios: Valuation Overview
Price to Earnings Ratio (P/E)
The Cipla Ltd P/E ratio currently stands at 22.10, making it one of the most tracked metrics in Cipla Ltd Ratios.
Historically, the Cipla Ltd P/E ratio has shown strong fluctuations:
- 2025: 22.10
- 2024: 29.30
- 2023: 25.96
- 2022: 32.68
- 2021: 27.37
The decline in Cipla Ltd P/E ratio suggests improving earnings relative to stock price.
Price to Book Ratio (P/B)
The Cipla Ltd P/B ratio reflects how the market values the company's net assets. Current P/B ratio is 3.73.
Historical P/B trend:
- 2025: 3.73
- 2024: 4.52
- 2023: 3.11
- 2022: 3.94
Cipla Ltd is trading at a premium to its book value, indicating strong market confidence.
Price to Sales Ratio (P/S)
The Cipla Ltd P/S ratio currently stands at 4.24, an important part of Cipla Ltd Ratios for revenue valuation.
Historical P/S ratio:
- 2025: 4.24
- 2024: 4.70
- 2023: 3.20
- 2022: 3.79
A stable or declining Cipla Ltd P/S ratio indicates cautious market sentiment.
Cipla Ltd Price to Cash Flow Ratio (P/CF)
The Cipla Ltd Price to Cash Flow Ratio is a key valuation metric that shows how much investors pay for each unit of cash flow. Current P/CF ratio is 22.28.
Historical Cipla Ltd Price to Cash Flow Ratio:
- 2025: 22.28
- 2024: 28.23
- 2023: 22.13
- 2022: 24.94
- 2021: 17.80
The declining Cipla Ltd Price to Cash Flow Ratio suggests improving cash flow strength.
Cipla Ltd Enterprise Value Ratios
Enterprise Value (EV)
The Cipla Ltd EV currently stands at ₹106000Cr, representing the total company valuation including debt.
Historical EV trend:
- 2025: 106000Cr
- 2024: 114000Cr
- 2023: 67571Cr
- 2022: 78922Cr
Cipla Ltd enterprise value consolidation suggests stable valuation.
EV/EBITDA Ratio
The Cipla Ltd EV/EBITDA ratio is currently 14.93, a key metric in Cipla Ltd Ratios to assess valuation relative to earnings.
Historical EV/EBITDA:
- 2025: 14.93
- 2024: 17.85
- 2023: 13.31
- 2022: 17.14
Stable Cipla Ltd EV/EBITDA indicates balanced valuation.
Cipla Ltd Financial Strength Ratios
Debt to Equity Ratio (D/E)
The Cipla Ltd D/E ratio is currently 0.01, reflecting leverage and financial stability.
Historical D/E:
- 2025: 0.01
- 2024: 0.02
- 2023: 0.03
- 2022: 0.05
Cipla Ltd maintains a strong balance sheet with low debt levels.
Return on Equity (ROE %)
The Cipla Ltd ROE currently stands at 18.21%, showing profitability and capital efficiency.
Historical ROE:
- 2025: 18.21
- 2024: 16.45
- 2023: 12.66
- 2022: 12.85
Cipla Ltd maintains stable profitability levels.
Cipla Ltd Ratios Analysis Summary
The Cipla Ltd Ratios page provides a comprehensive view of the company's valuation and financial performance. Key metrics such as P/E, P/B, P/S, P/CF, EV, EV/EBITDA, D/E, and ROE help investors understand whether Cipla Ltd stock is undervalued, fairly valued, or overvalued.
Tracking Cipla Ltd Ratios regularly helps investors make informed decisions based on valuation trends, financial stability, and long-term growth potential.
